Published on 18 Nov 2023 on Simply Wall St. via Yahoo Finance
Kazia Therapeutics Limited's (NASDAQ:KZIA) large institutional owners must be happy as stock...
Key Insights
Given the large stake in the stock by institutions, Kazia Therapeutics' stock price might be vulnerable to their trading decisionsThe top 2 shareholders own 63% of the company 22% of Kazia Therapeutics is held by insiders
A look at the shareholders of Kazia Therapeutics Limited (NASDAQ:KZIA) can tell us which group is most powerful. We can see that institutions own the lion's share in the company with 53% ownership. Put another way, the group faces the maximum upside potential (or downside risk).